Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02921321 · ClinicalTrials.gov registry record
Pilot Study of Cardiac MR in Patients With Muscular Dystrophy
A clinical trial, sponsored by Children's National Research Institute.
- Completed
- Registry status
- 60
- Enrollment target
NCT02921321: Completed study, sponsored by Children's National Research Institute.
NCT02921321 is a clinical trial that has completed, run by Children's National Research Institute. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02921321 has completed, sponsored by Children's National Research Institute.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Muscular Dystrophy can affect the skeletal muscles and also the heart and breathing muscles, causing significant morbidity and mortality. As patients are now living longer, treatment of muscular dystrophies involves drugs that help improve heart function. However, better types of heart imaging studies are needed to understand how these treatments work. Researchers want to improve heart imaging to identify earlier indicators of heart dysfunction in muscular dystrophy patients and how these are changed by medical treatment. The new imaging indicators will also help identify candidates for entry into future clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-01 |
| Est. Completion | 2024-12-09 |
What the finished NCT02921321 record still lists
NCT02921321 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02921321 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02921321 about?
NCT02921321 is a clinical study titled "Pilot Study of Cardiac MR in Patients With Muscular Dystrophy". Muscular Dystrophy can affect the skeletal muscles and also the heart and breathing muscles, causing significant morbidity and mortality. As patients are now living longer, treatment of muscular dystrophies involves drugs that help improve heart function. However, better types of heart imaging studi...
What is the current status of trial NCT02921321?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2014-01. Estimated completion is 2024-12-09.
Who is sponsoring clinical trial NCT02921321?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia